• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconMartin Shkreli

Martin Shkreli

Page 3 of 8
Martin Shkreli, former chief executive officer of Turing Pharmaceuticals and KaloBios Pharmaceuticals Inc, departs after a hearing at U.S. Federal Court in Brooklyn, New York
HealthFormer Retrophin Chairman Says Martin Shkreli Lied ‘to My Face’
By ReutersJuly 12, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli On Trial For Securities Fraud
LeadershipProsecutors Seek Gag Order for ‘Pharma Bro’ Martin Shkreli
By Lisa Marie SegarraJuly 4, 2017
Former Turing Pharmaceuticals AG Chief Executive Officer Martin Shkreli Court Appearance
LeadershipMartin Shkreli Asks for $3M Bail Reduction to Help Pay Legal Fees
By Lisa Marie SegarraJune 17, 2017
Former Turing Pharmaceuticals AG Chief Executive Officer Martin Shkreli Court Appearance
Arts & EntertainmentThere’s a Martin Shkreli Musical Coming to New York City
By Abigail AbramsMarch 16, 2017
Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
HealthMartin Shkreli’s Harvard Talk Got Disrupted by a Fire Alarm and Protests
By Sy MukherjeeFebruary 16, 2017
Martin Shkreli, former chief executive officer for Turing Pharmaceuticals AG.
HealthMartin Shkreli Just Went to War Against the Pharmaceutical Industry
By Sy MukherjeeJanuary 24, 2017
Orlando Continues To Mourn The Mass Shooting At Gay Club That Killed 49
LeadershipMilo Yiannopoulos, Martin Shkreli Campus Event Cancelled Due to Protests
By Katie ReillyJanuary 14, 2017
House Oversight Hearing On Prescription Drug Price Increases
LeadershipMartin Shkreli Was Just Suspended From Twitter
By Madeline FarberJanuary 8, 2017
Martin Shkreli
LeadershipMartin Shkreli Is Looking for a Date to Donald Trump’s Inauguration
By Abigail AbramsJanuary 5, 2017
Ex-pharmaceutical executive Martin Shkreli exits the U.S. District Court for the Eastern District of New York in Brooklyn.
HealthMartin Shkreli Congratulates Australian Students for Recreating Life-Saving Drug
By ReutersDecember 2, 2016
The Fortune Guide to Dressing Up for Halloween
RetailThe Fortune Guide to Dressing Up for Halloween
By Christina AustinOctober 28, 2016
House Oversight Hearing On Prescription Drug Price Increases
LeadershipMartin Shkreli Does Not Apologize
By Ian MountOctober 28, 2016
House Oversight Hearing On Prescription Drug Price Increases
LeadershipMartin Shkreli Is Auctioning Off a Chance to Punch Him in the Face
By Megan McCluskey, TIME and Michelle TohSeptember 28, 2016
House Oversight Hearing On Prescription Drug Price Increases
FinanceHere’s Why Shares of Martin Shkreli’s Former Company Are Soaring Today
By Reuters and Fortune EditorsSeptember 7, 2016
Former KaloBios Pharmaceuticals Chief Executive Officer Martin Shkreli Court Appearance
HealthMartin Shkreli Has a Lot to Say About Mylan’s EpiPen
By Sy MukherjeeAugust 26, 2016
1
  • 1
  • 2
  • 3
  • 4
  • 5
...8
Most Popular
Success
Two-thirds of parents say their adult Gen Z kids still rely on them financially  for support—even though it's putting them under strainplaceholder alt text
By Fortune EditorsMarch 31, 2026
Economy
Jerome Powell says the $39 trillion national debt is ‘not unsustainable,’ but warns the trajectory ‘will not end well’placeholder alt text
By Fortune EditorsMarch 30, 2026
Personal Finance
Current price of gold as of April 1, 2026placeholder alt text
By Fortune EditorsApril 1, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.